Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01445717 · ClinicalTrials.gov registry record
Rapid Diagnostic Test for Detection of Group B Streptococcus in Pregnancy
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 358
- Enrollment target
NCT01445717 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 358 participants.
The verdict
NCT01445717 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 358 participants
- Enrollment target
Study Summary
This study evaluates the use of a new method of growing and detecting Group B streptococcus in pregnant women. This new method utilizes sandwiched-membrane petri technology and has the advantage of detecting GBS in less than 6 hours, with less cost, and the potential of allowing antibiotic sensitivities to be performed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01445717
The ClinicalTrials.gov registry entry for NCT01445717 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01445717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01445717 about?
NCT01445717 is a clinical study titled "Rapid Diagnostic Test for Detection of Group B Streptococcus in Pregnancy". This study evaluates the use of a new method of growing and detecting Group B streptococcus in pregnant women. This new method utilizes sandwiched-membrane petri technology and has the advantage of detecting GBS in less than 6 hours, with less cost, and the potential of allowing antibiotic sensitivi...
What is the current status of trial NCT01445717?
This trial is currently completed. The enrollment target is 358 participants. The study started on 2010-11. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01445717?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.